Form 4 for VMD VIEMED HEALTHCARE, INC.
Accepted 2024-01-19 00:00:00 ET · period of report 2024-01-17 · accession 0001729149-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-19 | 2024-01-17 | VMD | Trahan Jeremy | CLO | D - Sale to Iss | $7.39 | -1,221 | 3,789 | -24% | -$9,023 |
| DM | 2024-01-19 | 2024-01-17 | VMD | Trahan Jeremy | CLO | M - OptEx | — | +6,106 | 5,010 | New | — |
| D | 2024-01-19 | 2024-01-17 | VMD | Trahan Jeremy | CLO | F - Tax | $7.39 | -1,742 | 6,932 | -20% | -$12.9K |
| DM | 2024-01-19 | 2024-01-17 | VMD | Trahan Jeremy | CLO | M - OptEx | $0.00 | -6,106 | 2,442 | -71% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-01-17 | D | D | 1,221 | $7.39 | 3,789 | D | — | — | (F2) Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. |
| 2 | Common | Common Shares | 2024-01-17 | M | A | 4,885 | — | 8,674 | D | — | — | (F3) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. |
| 3 | Common | Common Shares | 2024-01-17 | F | D | 1,742 | $7.39 | 6,932 | D | — | — | (F4) Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. (F5) Per share value is based on the market closing price of the common shares for January 17, 2024. |
| 4 | Common | Common Shares | 2024-01-17 | M | A | 1,221 | — | 5,010 | D | — | — | (F1) Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. |
| 5 | Derivative | Restricted Stock Units | 2024-01-17 | M | D | 4,885 | $0.00 | 9,768 | D | — · — to 2026-01-17 | 4,885 Common Shares | (F3) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. (F6) Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| 6 | Derivative | Phantom Share Units | 2024-01-17 | M | D | 1,221 | — | 2,442 | D | — · — to 2026-01-17 | 1,221 Common Shares | (F1) Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. (F2) Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. |